Effects of enrofloxacin, flunixin and dexamethasone on indicators of oxidative and organ damage in lipopolysaccharide-induced endotoxemia

Basit Öğe Kaydı
dc.contributor.authorEr, Ayşe
dc.contributor.authorAltan, Feray
dc.contributor.authorÇetin, Gül
dc.contributor.authorÜney, Kamil
dc.contributor.authorTraş, Binyamin
dc.contributor.authorElmas, Muammer
dc.contributor.authorYazar, Tinver
dc.date.accessioned2024-04-24T17:58:16Z
dc.date.available2024-04-24T17:58:16Z
dc.date.issued2010
dc.departmentDicle Üniversitesien_US
dc.description.abstractThe aim of this study was to determine the effects of enrofloxacin, flunixm meglumme and dexamethasone on antioxidant status and markers of organ damage in endotoxemia. Rats were divided into four groups. The groups received the following drugs (simultaneously with lipopolysaccharide): enrofloxacin, flunixin meglumine, low-dose dexamethasone or high-dose dexamethasone, respectively. After the treatments, serum and plasma samples were collected at 1, 2, 4, 6, 8, 12, 24 and 48 h. The levels of malondialdehyde, nitric oxide, superoxide dismutase, vitamin C and 13,14-dihydro-15-keto-prostaglandin F2a were determined with ELISA. The cardiac, hepatic and renal damage markers were measured with autoanalyzer. Elevated levels of malondialdehyde were relatively inhibited by high-dose dexamethasone. Increases in the levels of nitric oxide were inhibited by low and high-dose dexamethasone while increases in the level of 13,14-dihydro-15-keto prostaglandin F2n were inhibited by all treatments except enrofloxacin. No treatments inhibited the decrease in vitamin C levels. Cardiac andhepatic damage was not inhibited completely whereas renal damage was inhibited by treatment with low or high-dose dexamethasone. The results show that although low-dose dexamethasone had antioxidant activity and protected against organ damage, high-dose dexamethasone may be more beneficial in the treatment of endotoxemia.en_US
dc.identifier.citationEr, A., Altan, F., Çetin, G., Üney, K., Traş, B., Elmas, M. ve diğerleri. (2010). Effects of enrofloxacin, flunixin and dexamethasone on indicators of oxidative and organ damage in lipopolysaccharide-induced endotoxemia. Journal of Animal and Veterinary Advances, 9(10),1495-1500.
dc.identifier.doi10.3923/javaa.2010.1495.1500
dc.identifier.endpage1500en_US
dc.identifier.issn1680-5593
dc.identifier.issue10en_US
dc.identifier.scopus2-s2.0-77957359356
dc.identifier.scopusqualityN/A
dc.identifier.startpage1495en_US
dc.identifier.urihttps://doi.org/10.3923/javaa.2010.1495.1500
dc.identifier.urihttps://hdl.handle.net/11468/23791
dc.identifier.volume9en_US
dc.identifier.wosWoSIDEksik
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoenen_US
dc.relation.ispartofJournal of Animal and Veterinary Advances
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDexamethasoneen_US
dc.subjectEndotoxemiaen_US
dc.subjectEnrofloxacinen_US
dc.subjectFlunixinen_US
dc.subjectOrgan damageen_US
dc.subjectOxidative stressen_US
dc.titleEffects of enrofloxacin, flunixin and dexamethasone on indicators of oxidative and organ damage in lipopolysaccharide-induced endotoxemiaen_US
dc.titleEffects of enrofloxacin, flunixin and dexamethasone on indicators of oxidative and organ damage in lipopolysaccharide-induced endotoxemia
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu